All News
Filter News
Found 808,979 articles
-
DURECT Corporation's Phase III Study Did Not Show Significant Results for Posidur
1/6/2012
-
Dried Licorice Root Fights the Bacteria That Cause Tooth Decay and Gum Disease, Journal of Natural Products Reveals
1/6/2012
-
Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Closes Previously Announced $5 Million Financing
1/6/2012
-
Scientists Helps Find Structure of Gene-Editing Protein, Iowa State University Study
1/6/2012
-
Why Humans Choose Running Over Walking, North China Coal Medical University Study
1/6/2012
-
Endo Pharmaceuticals to Pay Up to $180 Million Plus Royalties to BioDelivery Sciences International in Drug Pact
1/6/2012
-
Johnson & Johnson to Pay $1 Billion to Settle Risperdal Marketing Probe
1/6/2012
-
Gene Mutation Linked to Chemo-Resistant Colon Cancer, University of Magdeburg Study
1/6/2012
-
Civitas Therapeutics Announces Positive Results from Clinical Study of CVT-301, an Inhaled L-dopa for Parkinson's Disease
1/6/2012
-
A Gene for Depression Localized, Texas Biomedical Research Instittute Study
1/6/2012
-
Johnson & Johnson AIDS Vaccine Protects Monkeys in Study
1/6/2012
-
Atorvastatin Failed to Slow Atherosclerosis in Pediatric Lupus, Duke University Study
1/6/2012
-
Could Daily Aspirin Harm Seniors' Eyes? Netherlands Institute for Neuroscience Study
1/6/2012
-
Genome Institute of Singapore Scientists Identify Lung Cancer Stem Cells and New Drug Targets
1/6/2012
-
Scientists Create First Monkeys With Mixed Genomes, Oregon Health & Science University (OHSU) Study
1/6/2012
-
Diabetic Mice Provide a Surprising Breakthrough for Multiple Sclerosis Research, Tel Aviv University Study
1/6/2012
-
Babies' Sleep Problems May Persist Over Years, Children's National Medical Center Study
1/6/2012
-
INSYS Therapeutics Announces FDA Approval of SUBSYS(R) Fentanyl Sublingual Spray
1/6/2012
-
Alnylam Pharmaceuticals Files Clinical Trial Application for ALN-TTR02, an RNAi Therapeutic Targeting Transthyretin for the Treatment of Transthyretin-Mediated Amyloidosis
1/6/2012
-
KAI Pharmaceuticals, Inc. Announces Initiation of Second Phase 2 Study of KAI-4169
1/6/2012